This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69406237
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в грудні 1989 im Dezember 1989 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel scientific article published on 01 December 1989 artículu científicu espublizáu n'avientu de 1989
p:P577
wds:Q69406237-BB620BFC-4852-468D-88E2-F033523AE554
wdt:P577
1989-12-01T00:00:00Z
p:P407
wds:Q69406237-B85BF1EB-215F-4F36-8A64-374DBA634911
wdt:P407
wd:Q1860
p:P2860
wds:Q69406237-33807E90-BBF2-4A6C-BC77-485DED1872A6 wds:Q69406237-E9746E9B-A889-4DAF-AE2F-A5B19CC3381B
wdt:P2860
wd:Q39740429 wd:Q70838095
p:P2093
wds:Q69406237-F2E52B17-6691-4BBE-B2E9-F62C759442FB wds:Q69406237-53EB14B7-BF0E-4D06-8E6D-140907F3F979 wds:Q69406237-580DFC64-4950-4A00-8DF2-AC2EEC4E24A7 wds:Q69406237-4C4A350D-51EE-4C0B-BE75-BEA551AED5FE wds:Q69406237-4CC516E5-E362-4749-B224-39F89ADA8522 wds:Q69406237-59E9DD35-7694-4C72-8AC2-D51D1F76EAA3 wds:Q69406237-B8F14AC8-3676-4056-B734-AE7952914A49 wds:Q69406237-E717903B-53F7-492E-8382-CC303AF564F6 wds:Q69406237-001001E9-69AC-4382-A2D1-878BE48B6153
wdt:P2093
Levashov AV Kabanov AV Morozov GV Lebedev AS Chekhonin VP Alakhov VYu Batrakova EV Melik-Nubarov NS Arzhakov SA
rdfs:label
The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
skos:prefLabel
The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
schema:name
The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
p:P50
wds:Q69406237-E92E0E4F-FC4D-4ADD-85AC-21E704FA57FC
wdt:P50
wd:Q66851308
p:P1476
wds:Q69406237-ABCF5D35-46C1-4B22-98B7-8D22438E8475
wdt:P1476
The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
p:P304
wds:Q69406237-1671C87F-AD52-470F-B817-66B29F06D2AC
wdt:P304
343-345
p:P31
wds:Q69406237-60D8C22F-21CF-40AA-B558-0F597C043E9D
wdt:P31
wd:Q13442814
p:P921
wds:Q69406237-16A6802F-5ADA-431E-9922-B1C5334268D6
wdt:P921
wd:Q251347
p:P698
wds:Q69406237-5D1E27EC-89FC-4BC4-BB60-4FA40299146F
wdtn:P698
n10:2599097
wdt:P698
2599097
p:P1433
wds:Q69406237-2597454C-B6E9-4128-9CDD-1A0B603B4558
wdt:P1433
wd:Q1388051
p:P433
wds:Q69406237-3C71968D-6C6E-43B9-8A0D-BDD8F6680A0B
p:P478
wds:Q69406237-D263C72C-6624-4D15-A4AC-CA8018C777C8
wdt:P433
2
wdt:P478
258
p:P356
wds:Q69406237-8976AFB6-D663-41D5-BA3A-9F016DB43B62
wdtn:P356
n12:0014-5793(89)81689-8
wdt:P356
10.1016/0014-5793(89)81689-8